Real-time enrollment status for this central nervous system neoplasms clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 2:16 AM UTC
| NCT Number | NCT04541082 |
| Recruiting Status | Recruiting |
| Condition | Central Nervous System Neoplasms |
| Phase | PHASE1 |
| Target Enrollment | 102 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Jazz Pharmaceuticals |
| Last Updated on CT.gov | December 18, 2025 (Dec 18, 2025) |
As of July 19, 2026: Clinical trial NCT04541082 is currently recruiting participants. This phase1 study for central nervous system neoplasms is actively seeking new participants at 1 location across the United States. The study is sponsored by Jazz Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04541082 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04541082 was last updated Dec 18, 2025 (December 18, 2025). HelloStudys verifies this status automatically.